why neu is a potential multibagger

I found this online, I thought it was quite positive.

"For long term investors (approx. 5 years), the unfolding development of NNZ-2566 trial provides an opportunity to create a three tier investment structure that could provide exponential returns coupled with the safety of a hedging strategy especially while the share price hovers around the 2 cent mark. For example, 3 lots of 1 million shares are bought at below 2.4 cents. The 30 day MA is starting to trend upwards after 1 year due to positive additional safety trial results, the announcement of oral NNZ-2566 phase 1 trial and more funding from US army. Then add to this, a positive 1Q 2011 cardivascular safety trial, we should see the share price build to between 6 & 8 cents in 2011. At which point the first lot is sold to cover the long term investment. The second lot is sold after phase 2 results, if positive should net $0.20/share in the middle of 2012. The third lot is sold after phase 3 results & FDA registration, if positive should net $2.00/share in 2014/2015. The drugs financial success would outway any dilution Neuren has suffered over the years. Obviously at 2 cents/share this is purely a speculative strategy but could net impressive results with minimal outlay. "